Professional Summary

Professional Overview

Brett Summers is the Head of Marketing for the Cancer Screening Franchise at Roche, a leading global pharmaceutical and diagnostics company. With over 15 years of experience in the biopharmaceutical industry, Brett has developed a strong expertise in medical affairs, marketing, and strategic omnichannel activation, with a particular focus on hematology and oncology therapeutics.

Experience Summary

Current Role

As the Head of Marketing for the Cancer Screening Franchise at Roche, Brett is responsible for driving the marketing strategy and execution for the company's innovative cancer screening solutions. In this role, he oversees the development and implementation of comprehensive marketing campaigns, collaborates with cross-functional teams to ensure effective brand positioning, and leverages data-driven insights to optimize customer engagement and product uptake.

Career Progression

Prior to his current role, Brett held several leadership positions at Genentech, a member of the Roche Group. He served as the US Medical Affairs Omnichannel Activation Lead, where he spearheaded the integration of digital and traditional channels to enhance customer experiences and drive business outcomes. Additionally, he held the role of Senior Marketing Director/Head of US Marketing for the Hematology/Venclexta portfolio, where he successfully led the launch and commercialization of a breakthrough oncology treatment.

Earlier in his career, Brett worked as a Marketing Director in the Hematology division at Genentech, and held scientific roles at Rigel Pharmaceuticals Inc. and ChemoCentryx, where he conducted research and contributed to the advancement of novel therapeutic approaches.

Academic Background

Brett Summers holds a Ph.D. in Biochemistry from the University of California, San Diego, where his research focused on signaling pathways and their implications in disease pathogenesis.

Areas of Expertise

• Hematology and oncology therapeutic area expertise

• Medical affairs and omnichannel marketing strategy

• Brand positioning and launch excellence

• Data-driven decision making and customer insights

• Cross-functional collaboration and team leadership

Professional Impact

During his tenure at Genentech, Brett played a pivotal role in the successful launch and commercialization of a novel hematology/oncology treatment, Venclexta, which has since become a standard of care for certain blood cancer patients. His strategic approach to omnichannel activation and data-driven marketing initiatives have contributed to the product's widespread adoption and improved patient outcomes.

Conclusion

With a proven track record of leadership, strategic thinking, and a deep understanding of the biopharmaceutical industry, Brett Summers is poised to drive continued success in his role as the Head of Marketing for the Cancer Screening Franchise at Roche. His expertise, coupled with his commitment to innovation and patient-centric solutions, make him a valuable asset in the company's efforts to advance cancer screening and improve patient outcomes.